Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells
- 1 May 1997
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (8) , 1913-1918
- https://doi.org/10.1097/00001756-199705260-00024
Abstract
ENDOGENOUS expression of opioid receptor-like receptor (ORL1) in human neuroblastoma SK-N-SH cells was demonstrated by binding with nociceptin/ orphanin FQ (N/OFQ). Scatchard analysis of [3H]N/ OFQ saturation binding data gave Kd = 1.3 ± 0.1 nM and Bmax = 158 ± 2.5 fmol/mg protein. N/OFQ stimulation increased [35S]GTPγS binding to cell membranes and attenuated forskolin-induced cAMP accumulation in a concentration-dependent manner. The effects of N/OFQ were eliminated by the pretreatment of pertussis toxin (PTX) but not by the antagonists of opioid receptors, revealing mediation of N/OFQ signal transduction by ORL1 receptor and PTX sensitive G protein(s). The ability of N/OFQ to inhibit cAMP production was greatly reduced after prechallenging with N/OFQ, indicating that ORL1 undergoes homologous desensitization in neuronal cells.Keywords
This publication has 6 references indexed in Scilit:
- Under Siege: The Brain on OpiatesNeuron, 1996
- Increase by the ORL1 receptor (opioid receptor‐like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neuronesBritish Journal of Pharmacology, 1996
- Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTPγS binding in rat brainNeuroReport, 1996
- Opiate receptorsNeuropharmacology, 1995
- Delta opioid receptor in human neuroblastoma cell linesBrain Research, 1986
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980